fostamatinib disodium April 12, 2017 fostamatinib disodium Trade Name Orphan Indication Immune thrombocytopenic purpura USA Market Approval USA USA Designation Date 2015-08-25 00:00:00 Sponsor Rigel Pharmaceuticals, Inc.;1180 Veterans Boulevard;South San Francisco, California, 94080